Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in REPL — Replimune Group, Inc.

CIK 1705339 CAUSEWAY BAY, K3
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$501,747
+$186,392 QoQ
Shares Held
45,325
+10.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 199 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. REPL ranks #130 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 150,692 $74,853,236
2 REGN
Regeneron Pharmaceuticals, Inc.
 59,595 $37,159,864
3 ALNY
Alnylam Pharmaceuticals, Inc.
 63,265 $19,044,662
4 RPRX
Royalty Pharma plc
 259,390 $14,543,997
5 TWST
Twist Bioscience Corp
 100,108 $10,299,110
6 INCY
Incyte Corp
 83,084 $9,418,401
7 PRAX
Praxis Precision Medicines, Inc.
 27,185 $9,101,265
8 MRNA
Moderna, Inc.
 106,564 $7,462,676

All Filings in REPL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $501,747 45,325
2026-03-31 $315,355 41,223
2025-12-31 $392,221 40,352
2025-09-30 $158,096 37,732
2025-06-30 $371,060 39,942
2025-03-31 $432,432 44,352
2024-12-31 $456,534 37,699
2024-09-30 $408,664 37,287
2024-06-30 $219,645 24,405